IL6 and deafness: The expression of IL-6 and CCL-2 was higher in the permanent hearing damage model than in the temporary hearing damage model, suggesting that the inflammatory response is a potential therapeutic target for the treatment of deafness resulting from energy failure in the lateral cochlear wall.